MedTrace Logo

Growing Up: Intervening With HIV-Positive Adolescents in Resource-Poor Settings

NCT02921516 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 278

Last updated 2018-07-11

No results posted yet for this study

Summary

Despite overall declines in HIV incidence and mortality since ART scale-up in low and middle income countries, both have risen among youth. In addition, HIV-infected youth achieve inferior treatment outcomes compared to their adult counterparts in both high- and low-income countries, and these poorer outcomes are generally attributed to suboptimal adherence. Thus, there is a critical need for the development of adherence and risk reduction interventions for the growing cohort of these youth, and the proposed cognitive behavioral N'ap Grandi is one such intervention.

Conditions

  • HIV Infection

Interventions

BEHAVIORAL

N'ap Grandi

Eight 90-minute adolescent cognitive behavioral modules and four 90-minute caregiver cognitive behavioral modules, delivered in weekend workshops over a 1 month period, with the last two modules for joint participation of adolescents and caregivers.

BEHAVIORAL

N'ap Grandi - A

Eight 90-minute adolescent cognitive behavioral modules delivered in weekend workshops over a 1 month period.

BEHAVIORAL

Health Promotion - A

Eight 90-minute adolescent health promotion modules delivered in weekend workshops over a 1 month period.

Sponsors & Collaborators

  • Florida International University

    lead OTHER

Principal Investigators

  • Jessy G. Dévieux, Ph.D. · Florida International University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2018-05-31
Completion
2018-05-31

Countries

  • Haiti

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02921516 on ClinicalTrials.gov